Besides, CTLA-4 is constitutively expressed on CD4+ Tregs, later work demonstrated that the CTLA-4 antibody acted, at least partially, through Fcγ receptor (FcγR)-dependent depletion of tumor-infiltrating Treg cells (34). Here, CTLA4 is linked to neoplasm.